What is Bristol-Myers Squibb's other noncash income (expense)?

Bristol-Myers Squibb (BMY) reported other noncash income (expense) of -$21M in Q1 2026.

How has Bristol-Myers Squibb's other noncash income (expense) changed year-over-year?

Bristol-Myers Squibb's other noncash income (expense) decreased by 320.0% year-over-year, from -$5M to -$21M.

What does other noncash income (expense) mean?

This captures miscellaneous non-cash adjustments to net income that do not fit into standard categories like depreciation or stock-based compensation. It includes items such as changes in fair value of certain liabilities or non-cash impairment charges.

Bristol-Myers Squibb BMY Other Noncash Income (Expense)

Other Noncash Income (Expense) at other companies

Tango TherapeuticsTNGX

-$21K-138%

PfizerPFE

——

Merck & Co.MRK

——

IncyteINCY

——

Gilead SciencesGILD

——

ImmunityBio, Inc.IBRX

——

Other financials

Income statement

See full

Revenue$11.5B+2.6%

Gross profit$8.1B-1.2%

Net income$2.7B+9.0%

EPS (diluted)$1.31+9.2%

Balance sheet

See full

Cash & equivalents$9.6B-12.0%

Total debt$44.7B-10.5%

Total equity$20.1B+15.4%

Total assets$86.5B-6.4%

Cash flow

See full

Operating cash flow$1.1B-43.5%

CapEx$347.0M+33.5%

Free cash flow$757.0M-55.3%

Valuation

See full

Market cap$118.32B+25.1%

Enterprise value$153.4B+16.8%

P/E16.3×-2.7×

P/S2.4×+0.5×

Profitability

See full

Gross margin70.5%0.0pp

Net margin15%+3.8pp

FCF margin24.6%-2.9pp

Returns & leverage

See full

Return on equity38.8%+7.3pp

Debt / equity2.2×-0.6×

Current ratio1.4×+0.1×

Where this comes from

Reported directly by Bristol-Myers Squibb in its filing.

Tagged under the XBRL concept us-gaap:OtherNoncashIncomeExpense.

The official record: Bristol-Myers Squibb’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Bristol-Myers Squibb's other noncash income (expense).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Bristol-Myers Squibb's other noncash income (expense)?: Bristol-Myers Squibb (BMY) reported other noncash income (expense) of -$21M in Q1 2026.
How has Bristol-Myers Squibb's other noncash income (expense) changed year-over-year?: Bristol-Myers Squibb's other noncash income (expense) decreased by 320.0% year-over-year, from -$5M to -$21M.
What does other noncash income (expense) mean?: This captures miscellaneous non-cash adjustments to net income that do not fit into standard categories like depreciation or stock-based compensation. It includes items such as changes in fair value of certain liabilities or non-cash impairment charges.